B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a treatment called anti-CD19 CAR T-cell therapy for people with advanced B-cell leukemias or lymphomas that haven't responded to standard drugs. Participants' own immune cells are collected, modified to recognize and attack cancer cells, and then returned to the …
Matched conditions: B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New hope for blood cancer patients: drug aims to cut Life-Threatening infections
Prevention Recruiting nowThis study tests whether a medicine called XEMBIFY, given every two weeks along with standard care, can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who also have low antibody le…
Matched conditions: B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Prevention
Last updated May 17, 2026 08:53 UTC